Most Recent
Westpac has lost a dispute with a part-time employee who asked to work from home to care for two young children and was told by a manager that “working from home is no substitution for childcare”.
A judge has refused to recuse himself from a sexual harassment case against the Western Australian Department of Justice after counsel for the department donated $500 to a GoFundMe for his brother-in-law.
Construction PRO
A group of investors have won a dispute against a Newcastle-based company over a foreclosure on a mortgage in relation to a Gold Coast which did not proceed.
Former Keybridge CEO Nicholas Bolton, who was voted out in a board spill earlier this year, has lost his bid to bring a derivative suit against director Frank Catalano over a failed bid to acquire a rural publisher previously owned by Nine.
An appeals court has overturned the dismissal of a sexual harassment case and ordered a new trial after finding a judge did not consider crucial evidence and relied on "a preconception of how a victim would act".
A judge has struck down controversial new anti-protest laws in New South Wales which gave police powers to shut down protests “in or near a place of worship”, finding they were contrary to the freedom of political communication.
Blooms the Chemist can't overturn a decision from the Pharmacy Council of NSW blocking the registration of a chemist, with a judge finding there was no evidence Blooms would not have a financial interest in the business.
The High Court has upheld a decision to refuse a visa for conservative US commentator Candace Owens, finding the Migration Act's character test did not infringe on the Constitution's implied freedom of political communication.
Construction PRO
A luxury Hamilton Island resort has lost its bid to vary the form of security ordered last year in its $15 million suit over allegedly defective rectification works completed in the wake of Cyclone Debbie.
Samsung Bioepis has successfully opposed Janssen's bid to patent a monoclonal antibody to treat ulcerative colitis, but an IP Australia delegate has given the J&J-owned company a chance to fix its application.